This is a turnkey, fully online Nationwide telehealth platform specializing in GLP-1 weight loss programs, offering compounded medications such as Semaglutide and Tirzepatide to patients nationwide. The business operates with a streamlined, fully remote model, requiring no physical location and maintaining low overhead while servicing customers across the United States.

The platform is built for scalability, with an established digital infrastructure that includes a proprietary website (trygenesis.com), patient acquisition funnels, and automated onboarding processes. The company has developed relationships with U.S.-based licensed medical providers and compounding pharmacies, allowing for seamless patient care and fulfillment, including fast nationwide shipping.

Demand for GLP-1 weight loss solutions continues to grow rapidly, and this business is well-positioned within one of the fastest-expanding sectors in healthcare. With strong fundamentals already in place, there is significant opportunity for a new owner to scale revenue through enhanced marketing, brand expansion, and customer retention strategies.

This is an ideal acquisition for an operator or group looking to enter or expand within the telehealth or weight loss space with a ready-to-scale, nationwide platform.